Literature DB >> 2031856

Aromatase in the human choriocarcinoma JEG-3: inhibition by R 76 713 in cultured cells and in tumors grown in nude mice.

M D Krekels1, W Wouters, R De Coster, R Van Ginckel, A Leonaers, P A Janssen.   

Abstract

The aromatase enzyme and its inhibition by R 76 713 were characterized in the JEG-3 choriocarcinoma cell line in culture and in JEG-3 tumors grown in nude mice. Optimal cell culture parameters and enzyme reaction conditions for the determination of aromatase activity were established. Under these conditions, in vitro JEG-3 aromatase was inhibited by R 76 713 with IC50-values of 7.6 +/- 0.5 nM and 2.7 +/- 1.1 nM using 500 nM of androstenedione and testosterone as substrate respectively. The Km-value of the aromatase enzyme with androstenedione as substrate was 62 +/- 19 nM; with testosterone as substrate, a value of 166 +/- 27 nM was found. In the presence of increasing concentrations of R 76 713, the Km-values increased while the Vmax remained unchanged. Using androstenedione and testosterone as substrate Lineweaver-Burk analysis of the data showed Ki-values for R 76 713 of 0.43 +/- 0.06 nM and 0.47 +/- 0.39 nM respectively. R 76 713 appeared to competitively inhibit the JEG-3 aromatase. Aromatase could easily be measured in homogenates of JEG-3 tumors grown in nude mice and showed Km-values similar to those found for JEG-3 cells in vitro. IC50-values for inhibition of tumor aromatase by R 76 713 were also similar to those found in cultured cells. Tumor aromatase measured ex vivo, 2 h after a single oral administration of R 76 713 was dose-dependently inhibited. An ED50-value of 0.05 mg/kg was calculated. The JEG-3 choriocarcinoma proved to be a useful aromatase model enabling the comparative study of aromatase inhibition in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2031856     DOI: 10.1016/0960-0760(91)90329-4

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  4 in total

Review 1.  Aromatase inhibitors--mechanisms for non-steroidal inhibitors.

Authors:  H V Vanden Bossche; H Moereels; L M Koymans
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 2.  Vorozole, a specific non-steroidal aromatase inhibitor.

Authors:  W Wouters; E Snoeck; R De Coster
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

3.  The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer.

Authors:  Maša Sinreih; Tamara Knific; Maja Anko; Neli Hevir; Katja Vouk; Aleš Jerin; Snježana Frković Grazio; Tea Lanišnik Rižner
Journal:  Front Pharmacol       Date:  2017-06-23       Impact factor: 5.810

4.  Determining the IC 50 Values for Vorozole and Letrozole, on a Series of Human Liver Cytochrome P450s, to Help Determine the Binding Site of Vorozole in the Liver.

Authors:  Lendelle Raymond; Nikita Rayani; Grace Polson; Kylie Sikorski; Ailin Lian; Melissa A VanAlstine-Parris
Journal:  Enzyme Res       Date:  2015-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.